Cargando…
Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
Pharmaceutical expenditures in ambulatory care rose rapidly in Europe in the 1990s and early 2000s. This was typically faster than other components of healthcare spending, leading to reforms to moderate future growth. A number of these centered on generic medicines with measures to lower reimbursed...
Autores principales: | Godman, Brian, Shrank, William, Wettermark, Bjorn, Andersen, Morten, Bishop, Iain, Burkhardt, Thomas, Garuolienè, Kristina, Kalaba, Marija, Laius, Ott, Joppi, Roberta, Sermet, Catherine, Schwabe, Ulrich, Teixeira, Inês, Tulunay, F. Cankat, Wendykowska, Kamila, Zara, Corinne, Gustafsson, Lars L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033935/ https://www.ncbi.nlm.nih.gov/pubmed/27713363 http://dx.doi.org/10.3390/ph3082470 |
Ejemplares similares
-
Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications
por: Godman, Brian, et al.
Publicado: (2011) -
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
por: Adamski, Jakub, et al.
Publicado: (2010) -
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
por: Godman, Brian, et al.
Publicado: (2014) -
Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs
por: Malmström, Rickard E., et al.
Publicado: (2013) -
Different initiatives across Europe to enhance losartan utilization post generics: impact and implications
por: Moon, James C., et al.
Publicado: (2014)